GWM
OMCL icon

Geneos Wealth Management’s Omnicell OMCL Stock Holding History

Geneos Wealth Management’s Portfolio OMCL Stock Details OMCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-30
Closed -$4K – 3035
2021
Q1 		$4K Buy
+30
New +$3.85K ﹤0.01% 2733
2017
Q1 		– Sell
-48
Closed -$1K – 2114
2016
Q4 		$1K Hold
48
– – ﹤0.01% 1977
2016
Q3 		$1K Buy
+48
New +$1.79K ﹤0.01% 1904

Other funds holding OMCL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geneos Wealth Management's OMCL Position: Q2 2021 in Review

Geneos Wealth Management sold out of Omnicell (OMCL) in Q2 2021, closing a stake of 30 shares — an estimated $4K sold.

Geneos Wealth Management first reported a position in OMCL in Q3 2016 and held it in 3 quarters. The position peaked at $4K in Q1 2021. 377 funds tracked by Wall St. Rank hold OMCL as of Q2 2021.

  • Geneos Wealth Management reported no remaining Omnicell position as of Q2 2021 after selling out during the quarter.
  • Geneos Wealth Management sold 30 Omnicell shares in Q2 2021, an estimated $4K.
  • Geneos Wealth Management first reported a position in Omnicell in Q3 2016 and held it in 3 quarters.
  • Geneos Wealth Management's Omnicell position peaked at $4K in Q1 2021.
  • 377 funds tracked by Wall St. Rank held Omnicell as of Q2 2021.

Based on Geneos Wealth Management's 13F filing for Q2 2021, filed 8 Jul 2021.